Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds
- PMID: 26745009
- DOI: 10.3109/14756366.2015.1128427
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds
Abstract
Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the fundamental reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho/physiological conditions. A series of benzothiazole-based sulfonamides were synthesized and tested as possible CA inhibitors. Their inhibitory activity was assessed against the cytosolic human isoforms hCA I and hCA II and the transmembrane hCA IX and hCA XII. Several of the investigated derivatives showed interesting inhibition activity and selectivities for inhibiting hCA IX and hCA XII over the off-target ones hCA I and hCA II. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds, within the active site of hCA IX.
Keywords: Benzothiazole sulfonamides; carbonic anhydrase; docking; metalloenzyme; molecular dynamic simulations.
Similar articles
-
Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.Int J Mol Sci. 2021 May 11;22(10):5082. doi: 10.3390/ijms22105082. Int J Mol Sci. 2021. PMID: 34064890 Free PMC article.
-
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.Bioorg Med Chem. 2015 Aug 1;23(15):4989-4999. doi: 10.1016/j.bmc.2015.05.019. Epub 2015 May 19. Bioorg Med Chem. 2015. PMID: 26048024
-
Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.Bioorg Med Chem. 2017 Oct 15;25(20):5726-5732. doi: 10.1016/j.bmc.2017.08.047. Epub 2017 Sep 1. Bioorg Med Chem. 2017. PMID: 28887000
-
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors.Curr Pharm Des. 2010;16(29):3317-26. doi: 10.2174/138161210793429805. Curr Pharm Des. 2010. PMID: 20819062 Review.
-
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors.Eur J Med Chem. 2021 Jan 1;209:112923. doi: 10.1016/j.ejmech.2020.112923. Epub 2020 Oct 15. Eur J Med Chem. 2021. PMID: 33121862 Review.
Cited by
-
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.J Enzyme Inhib Med Chem. 2017 Dec;32(1):1240-1252. doi: 10.1080/14756366.2017.1375484. J Enzyme Inhib Med Chem. 2017. PMID: 28936880 Free PMC article.
-
Discovery of a new potent oxindole multi-kinase inhibitor among a series of designed 3-alkenyl-oxindoles with ancillary carbonic anhydrase inhibitory activity as antiproliferative agents.BMC Chem. 2023 Jul 18;17(1):81. doi: 10.1186/s13065-023-00994-3. BMC Chem. 2023. PMID: 37461110 Free PMC article.
-
Molecular Cloning and Characterization of Carbonic Anhydrase XII from Pufferfish (Takifugu rubripes).Int J Mol Sci. 2018 Mar 13;19(3):842. doi: 10.3390/ijms19030842. Int J Mol Sci. 2018. PMID: 29534037 Free PMC article.
-
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors.J Enzyme Inhib Med Chem. 2018 Dec;33(1):956-961. doi: 10.1080/14756366.2018.1469017. J Enzyme Inhib Med Chem. 2018. PMID: 29747534 Free PMC article.
-
Benzothiazole derivatives as anticancer agents.J Enzyme Inhib Med Chem. 2020 Dec;35(1):265-279. doi: 10.1080/14756366.2019.1698036. J Enzyme Inhib Med Chem. 2020. PMID: 31790602 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources